SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Uranium Royalty Corp. (UROY) trades at a trailing P/E of 161.0, forward P/E of 15.9. Trailing earnings yield is 0.62%, forward earnings yield 6.28%. Graham Number is $1.37.
Criteria proven by this page:
- VALUE (58/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 15.9 (down from trailing 161.0) — analysts expect earnings to grow, which would improve the valuation.
- Trailing Earnings Yield 0.62% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 6.28% as earnings recover.
Overall SharesGrow Score: 55/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
58/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — UROY
Valuation Multiples
P/E (TTM)161.0
Forward P/E15.9
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.85
P/S Ratio13.40
EV/EBITDA115.5
Per Share Data
EPS (TTM)$0.03
Forward EPS (Est.)$0.23
Book Value / Share$2.70
Revenue / Share$0.39
FCF / Share$0.28
Yields & Fair Value
Earnings Yield0.62%
Forward Earnings Yield6.28%
Dividend Yield0.00%
Graham Number$1.37
SharesGrow IV$1.24 (-66.8%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2018 |
-154.2 |
0.00 |
23.91 |
0.00 |
- |
| 2019 |
-13.6 |
-0.01 |
1.75 |
0.00 |
- |
| 2020 |
-22.7 |
0.50 |
0.87 |
0.00 |
- |
| 2021 |
-226.2 |
3.67 |
4.12 |
0.00 |
- |
| 2022 |
-89.8 |
-0.59 |
2.32 |
0.00 |
- |
| 2023 |
-42.5 |
-1.78 |
1.42 |
17.93 |
- |
| 2024 |
35.0 |
-0.14 |
1.24 |
8.03 |
- |
| 2025 |
-56.0 |
0.37 |
1.07 |
20.30 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2017 |
$-0.01 |
$0.00 |
$-322.06K |
- |
| 2018 |
$-0.09 |
$0.00 |
$-3.82M |
- |
| 2019 |
$-0.05 |
$0.00 |
$-2.7M |
- |
| 2020 |
$-0.02 |
$0.00 |
$-1.38M |
- |
| 2021 |
$-0.05 |
$0.00 |
$-4.26M |
- |
| 2022 |
$-0.06 |
$13.85M |
$-5.84M |
-42.2% |
| 2023 |
$0.08 |
$42.71M |
$9.78M |
22.9% |
| 2025 |
$-0.04 |
$15.6M |
$-5.65M |
-36.3% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.23 |
$-0.23 – $0.70 |
$256.02M |
$256.02M – $256.02M |
1 |
| 2027 |
$0.01 |
$0.01 – $0.01 |
$694.9K |
$694.9K – $694.9K |
1 |
| 2028 |
$0.03 |
$0.03 – $0.03 |
$3.97M |
$3.97M – $3.97M |
1 |
